HCPCS Code Descriptor:
Injection, belantamab mafodotin-blmf, 0.5 mg
Route of Administration:
BLENREP is an Oncology drug manufactured by GSK and administered via the Intravenous route of administration. The J Code: J9037 is aligned to the drug BLENREP.